Buer Gene P

SEC source: 0001005229-17-000352 · wf-form4_150972127892713.xml · nonDerivative · entry 2

Buer Gene P · CIK 0001464160 · Former VP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

SEC source: 0001005229-17-000352 · wf-form4_150972127892713.xml · nonDerivative · entry 1

Buer Gene P · CIK 0001464160 · Former VP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,136

SEC source: 0001005229-17-000335 · wf-form4_150706288581388.xml · nonDerivative · entry 1

Buer Gene P · CIK 0001464160 · VP Global Svs/Vertical Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,529

F1 · shares: 10,800.1722 restricted stock units became fully vested upon reporting persons retirement on September 30, 2017, of which 3,826 shares were withheld to satisfy tax withholding obligations and 3.1722 shares were issued in cash of $120.35.

SEC source: 0001005229-17-000308 · wf-form4_150351754168231.xml · nonDerivative · entry 1

Buer Gene P · CIK 0001464160 · VP Global Svs/Vertical Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,358.1722

F1 · shares: Represents additional restricted stock units attributable to dividend reinvestment.

F2 · balance_after: Includes 10,800.1722 shares of restricted stock issued to reporting person subject to forfeiture in whole or part; 842.0093 shares become fully vested and non-forfeitable on 5/19/2018; 1,846.9794 shares become fully vested and non-forfeitable 50% per year for two years beginning 5/18/2018; 4,492.4625 shares become fully vested and non-forfeitable 33.33% per year for three years beginning 5/23/2018; and the remaining 3,618.7210 shares become fully vested and non-forfeitable 25% per year for four years beginning 5/22/2018, if reporting person remains an employee of issuer.

SEC source: 0001005229-17-000279 · wf-form4_150238015785236.xml · derivative · entry 24

Buer Gene P · CIK 0001464160 · VP Global Svs/Vertical Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,926

Underlying: Common Stock · 4,641 shares

Expires 2026-05-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · balance_after: Exercisable 33.33% per year for three years beginning 5/23/2018, if reporting person remains an employee of issuer.

SEC source: 0001005229-17-000279 · wf-form4_150238015785236.xml · derivative · entry 23

Buer Gene P · CIK 0001464160 · VP Global Svs/Vertical Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,222

Underlying: Common Stock · 5,222 shares

Expires 2025-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · balance_after: Exercisable 50% per year for two years beginning 5/18/2018, if reporting person remains an employee of issuer.

SEC source: 0001005229-17-000279 · wf-form4_150238015785236.xml · derivative · entry 22

Buer Gene P · CIK 0001464160 · VP Global Svs/Vertical Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,082

Underlying: Common Stock · 6,243 shares

Expires 2024-05-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Exercisable on 5/19/2018, if reporting person remains an employee of issuer.

SEC source: 0001005229-17-000279 · wf-form4_150238015785236.xml · derivative · entry 21

Buer Gene P · CIK 0001464160 · VP Global Svs/Vertical Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,299 shares

Expires 2023-05-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001005229-17-000279 · wf-form4_150238015785236.xml · derivative · entry 20

Buer Gene P · CIK 0001464160 · VP Global Svs/Vertical Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,360 shares

Expires 2022-05-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001005229-17-000279 · wf-form4_150238015785236.xml · derivative · entry 19

Buer Gene P · CIK 0001464160 · VP Global Svs/Vertical Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,230 shares

Expires 2021-05-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001005229-17-000279 · wf-form4_150238015785236.xml · derivative · entry 18

Buer Gene P · CIK 0001464160 · VP Global Svs/Vertical Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,622 shares

Expires 2020-05-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001005229-17-000279 · wf-form4_150238015785236.xml · derivative · entry 17

Buer Gene P · CIK 0001464160 · VP Global Svs/Vertical Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 432 shares

Expires 2018-05-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001005229-17-000279 · wf-form4_150238015785236.xml · nonDerivative · entry 16

Buer Gene P · CIK 0001464160 · VP Global Svs/Vertical Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,344.1881

SEC source: 0001005229-17-000279 · wf-form4_150238015785236.xml · nonDerivative · entry 15

Buer Gene P · CIK 0001464160 · VP Global Svs/Vertical Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,332.1881

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001005229-17-000279 · wf-form4_150238015785236.xml · nonDerivative · entry 14

Buer Gene P · CIK 0001464160 · VP Global Svs/Vertical Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,691.1881

SEC source: 0001005229-17-000279 · wf-form4_150238015785236.xml · nonDerivative · entry 13

Buer Gene P · CIK 0001464160 · VP Global Svs/Vertical Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,143.1881

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001005229-17-000279 · wf-form4_150238015785236.xml · nonDerivative · entry 12

Buer Gene P · CIK 0001464160 · VP Global Svs/Vertical Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,921.1881

SEC source: 0001005229-17-000279 · wf-form4_150238015785236.xml · nonDerivative · entry 11

Buer Gene P · CIK 0001464160 · VP Global Svs/Vertical Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,533.1881

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001005229-17-000279 · wf-form4_150238015785236.xml · nonDerivative · entry 10

Buer Gene P · CIK 0001464160 · VP Global Svs/Vertical Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,290.1881

SEC source: 0001005229-17-000279 · wf-form4_150238015785236.xml · nonDerivative · entry 9

Buer Gene P · CIK 0001464160 · VP Global Svs/Vertical Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,028.1881

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001005229-17-000279 · wf-form4_150238015785236.xml · nonDerivative · entry 8

Buer Gene P · CIK 0001464160 · VP Global Svs/Vertical Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,729.1881

SEC source: 0001005229-17-000279 · wf-form4_150238015785236.xml · nonDerivative · entry 7

Buer Gene P · CIK 0001464160 · VP Global Svs/Vertical Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,803.1881

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001005229-17-000279 · wf-form4_150238015785236.xml · nonDerivative · entry 6

Buer Gene P · CIK 0001464160 · VP Global Svs/Vertical Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,443.1881

SEC source: 0001005229-17-000279 · wf-form4_150238015785236.xml · nonDerivative · entry 5

Buer Gene P · CIK 0001464160 · VP Global Svs/Vertical Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,822.1881

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001005229-17-000279 · wf-form4_150238015785236.xml · nonDerivative · entry 4

Buer Gene P · CIK 0001464160 · VP Global Svs/Vertical Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,592.1881

SEC source: 0001005229-17-000279 · wf-form4_150238015785236.xml · nonDerivative · entry 3

Buer Gene P · CIK 0001464160 · VP Global Svs/Vertical Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,743.1881

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001005229-17-000279 · wf-form4_150238015785236.xml · nonDerivative · entry 2

Buer Gene P · CIK 0001464160 · VP Global Svs/Vertical Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,121.1881

SEC source: 0001005229-17-000279 · wf-form4_150238015785236.xml · nonDerivative · entry 1

Buer Gene P · CIK 0001464160 · VP Global Svs/Vertical Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,522.1881

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001005229-17-000272 · wf-form4_150176852929050.xml · nonDerivative · entry 1

Buer Gene P · CIK 0001464160 · VP Global Svs/Vertical Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,090.1881

F1 · balance_after: Includes 10,786.1881 shares of restricted stock issued to reporting person subject to forfeiture in whole or part; 840.9355 shares become fully vested and non-forfeitable on 5/19/2018; 1,844.6098 shares become fully vested and non-forfeitable 50% per year for two years beginning 5/18/2018; 4,486.6428 shares become fully vested and non-forfeitable 33.33% per year for three years beginning 5/23/2018; and the remaining 3,614 shares become fully vested and non-forfeitable 25% per year for four years beginning 5/22/2018, if reporting person remains an employee of issuer.

SEC source: 0001005229-17-000213 · wf-form4_149788551490487.xml · nonDerivative · entry 1

Buer Gene P · CIK 0001464160 · VP Global Svs/Vertical Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,759.1881

F1 · balance_after: Includes 10,786.1881 shares of restricted stock issued to reporting person subject to forfeiture in whole or part; 840.9355 shares become fully vested and non-forfeitable on 5/19/2018; 1,844.6098 shares become fully vested and non-forfeitable 50% per year for two years beginning 5/18/2018; 4,486.6428 shares become fully vested and non-forfeitable 33.33% per year for three years beginning 5/23/2018; and the remaining 3,614 shares become fully vested and non-forfeitable 25% per year for four years beginning 5/22/2018, if reporting person remains an employee of issuer.

SEC source: 0001005229-17-000190 · wf-form4_149572174941877.xml · nonDerivative · entry 1

Buer Gene P · CIK 0001464160 · VP Global Svs/Vertical Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,906.1881

F1 · shares: Represents shares withheld to satisfy tax withholding obligation upon vesting of 1,495.5476 shares of restricted stock on 5/23/2017.

F2 · balance_after: Includes 10,786.1881 shares of restricted stock issued to reporting person subject to forfeiture in whole or part; 840.9355 shares become fully vested and non-forfeitable on 5/19/2018; 1,844.6098 shares become fully vested and non-forfeitable 50% per year for two years beginning 5/18/2018; 4,486.6428 shares become fully vested and non-forfeitable 33.33% per year for three years beginning 5/23/2018; and the remaining 3,614 shares become fully vested and non-forfeitable 25% per year for four years beginning 5/22/2018, if reporting person remains an employee of issuer.

SEC source: 0001005229-17-000171 · wf-form4_149564023934559.xml · derivative · entry 2

Buer Gene P · CIK 0001464160 · VP Global Svs/Vertical Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,926

Underlying: Common Stock · 11,926 shares

Expires 2027-05-21

F3 · shares: Represents non-qualified stock options issued to reporting person under the Columbus McKinnon Corporation 2016 Long Term Incentive Plan dated as of July 18, 2016 subject to forfeiture in whole or part; options become exercisable 25% per year for four years beginning 5/22/2018, if reporting person remains an employee of issuer.

F3 · balance_after: Represents non-qualified stock options issued to reporting person under the Columbus McKinnon Corporation 2016 Long Term Incentive Plan dated as of July 18, 2016 subject to forfeiture in whole or part; options become exercisable 25% per year for four years beginning 5/22/2018, if reporting person remains an employee of issuer.

SEC source: 0001005229-17-000171 · wf-form4_149564023934559.xml · nonDerivative · entry 1

Buer Gene P · CIK 0001464160 · VP Global Svs/Vertical Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,372.7357

F1 · shares: Represents restricted stock units issued to reporting person under the Columbus McKinnon Corporation 2016 Long Term Incentive Plan dated as of July 18, 2016, subject to forfeiture in whole or part; units become fully vested and non-forfeitable 25% per year for four years beginning 5/22/2018, if reporting person remains an employee of issuer.

F2 · balance_after: Includes 12,281.7357 shares of restricted stock issued to reporting person subject to forfeiture in whole or part; 840.9355 shares become fully vested and non-forfeitable on 5/19/2018; 1,844.6098 shares become fully vested and non-forfeitable 50% per year for two years beginning 5/18/2018; 5,982.1904 shares become fully vested and non-forfeitable 25% per year for four years beginning 5/23/2017; and the remaining 3,614 shares become fully vested and non-forfeitable 25% per year for four years beginning 5/22/2018, if reporting person remains an employee of issuer.

SEC source: 0001005229-17-000154 · wf-form4_149556741739732.xml · nonDerivative · entry 1

Buer Gene P · CIK 0001464160 · VP Global Svs/Vertical Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,758.7357

F1 · shares: Represents shares withheld to satisfy tax withholding obligation upon vesting of 1,129.0110 shares of restricted stock on 5/20/2017.

F2 · balance_after: Includes 8,667.7357 shares of restricted stock issued to reporting person subject to forfeiture in whole or part; 840.9355 shares become fully vested and non-forfeitable on 5/19/2018; 1,844.6098 shares become fully vested and non-forfeitable 50% per year for two years beginning 5/18/2018; and the remaining 5,982.1904 shares become fully vested and non-forfeitable 25% per year for four years beginning 5/23/2017, if reporting person remains an employee of issuer.

SEC source: 0001005229-17-000141 · wf-form4_149548197461574.xml · nonDerivative · entry 1

Buer Gene P · CIK 0001464160 · VP Global Svs/Vertical Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,104.7467

F1 · shares: Represents shares withheld to satisfy tax withholding obligation upon vesting of 839.9126 shares of restricted stock on 5/19/2017.

F2 · balance_after: Includes 9,796.7467 shares of restricted stock issued to reporting person subject to forfeiture in whole or part; 1,129.0110 shares become fully vested and non-forfeitable on 5/20/2017; 840.9355 shares become fully vested and non-forfeitable on 5/19/2018; 1,844.6098 shares become fully vested and non-forfeitable 50% per year for two years beginning 5/18/2018; and the remaining 5,982.1904 shares become fully vested and non-forfeitable 25% per year for four years beginning 5/23/2017, if reporting person remains an employee of issuer.

SEC source: 0001005229-17-000127 · wf-form4_149522238439982.xml · nonDerivative · entry 1

Buer Gene P · CIK 0001464160 · VP Global Svs/Vertical Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,361.6593

F1 · shares: Represents shares withheld to satisfy tax withholding obligation upon vesting of 922.3049 shares of restricted stock on 5/18/2017.

F2 · balance_after: Includes 10,636.6593 shares of restricted stock issued to reporting person subject to forfeiture in whole or part; 1,129.0110 shares become fully vested and non-forfeitable on 5/20/2017; 1,680.8481 shares become fully vested and non-forfeitable 50% per year for two years beginning 5/19/2017; 1,844.6098 shares become fully vested and non-forfeitable 50% per year for two years beginning 5/18/2018; and the remaining 5,982.1904 shares become fully vested and non-forfeitable 25% per year for four years beginning 5/23/2017, if reporting person remains an employee of issuer.

SEC source: 0001005229-17-000103 · wf-form4_149503795386986.xml · nonDerivative · entry 1

Buer Gene P · CIK 0001464160 · VP Global Svs/Vertical Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,677.9642

F1 · shares: Represents additional restricted stock units attributable to dividend reinvestment.

F2 · balance_after: Includes 11,558.9642 shares of restricted stock issued to reporting person subject to forfeiture in whole or part; 1,129.0110 shares become fully vested and non-forfeitable on 5/20/2017; 1,680.8481 shares become fully vested and non-forfeitable 50% per year for two years beginning 5/19/2017; 2,766.9147 shares become fully vested and non-forfeitable 33.33% per year for three years beginning 5/18/2017; and the remaining 5,982.1904 shares become fully vested and non-forfeitable 25% per year for four years beginning 5/23/2017, if reporting person remains an employee of issuer.

SEC source: 0001005229-17-000044 · wf-form4_148780257813299.xml · nonDerivative · entry 1

Buer Gene P · CIK 0001464160 · VP Global Svs/Vertical Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,659.5449

F1 · shares: Represents additional restricted stock units attributable to dividend reinvestment.

F2 · balance_after: Includes 11,540.5449 shares of restricted stock issued to reporting person subject to forfeiture in whole or part; 1,127.2314 shares become fully vested and non-forfeitable on 5/20/2017; 1,678.1949 shares become fully vested and non-forfeitable 50% per year for two years beginning 5/19/2017; 2,762.5206 shares become fully vested and non-forfeitable 33.33% per year for three years beginning 5/18/2017; and the remaining 5,972.5980 shares become fully vested and non-forfeitable 25% per year for four years beginning 5/23/2017, if reporting person remains an employee of issuer.

SEC source: 0001005229-16-000502 · wf-form4_147985080369286.xml · nonDerivative · entry 1

Buer Gene P · CIK 0001464160 · VP Global Svs/Vertical Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,642.7033

F1 · shares: Represents additional restricted stock units attributable to dividend reinvestment.

F2 · balance_after: Includes 11,523.7033 shares of restricted stock issued to reporting person subject to forfeiture in whole or part; 1,125.6042 shares become fully vested and non-forfeitable on 5/20/2017; 1,675.7689 shares become fully vested and non-forfeitable 50% per year for two years beginning 5/19/2017; 2,758.503 shares become fully vested and non-forfeitable 33.33% per year for three years beginning 5/18/2017; and the remaining 5,963.8272 shares become fully vested and non-forfeitable 25% per year for four years beginning 5/23/2017, if reporting person remains an employee of issuer.